Bristol Myers to sell 60% stake in China joint venture

U.S. drugmaker Bristol Myers Squibb said on Tuesday it has signed an agreement to sell its 60% ownership stake in a pharmaceutical joint venture in China. ...

Bristol-Myers Squibb-Bristol Myers to sell 60% stake in China joint venture - Reportify